News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Who Needs VCs? Steven Quay's Atossa Genetics, Inc. Seeks $15M IPO For Breast Cancer Test


5/21/2010 9:04:57 AM

Xconomy -- Most biotech firms toil as obscure private companies for years to prove their ideas work in the clinic. They have to hustle non-stop for venture capital to keep the doors open just long enough to someday cash out with an IPO.

Read at Xconomy

comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES